SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT (TFA)

CAT:
804-HY-158992S
Size:
1 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT (TFA) - image 1

SP-(Val-13C5,15N)-EKNQ-(Leu-13C6,15N)-TIDFINIVKDPVPHNEYKT (TFA)

  • UNSPSC Description:

    SP-(Val-13C5,15)-EKNQ-(Leu-13C6,15)-TIDFINIVKDPVPHNEYKT TFA is a 13C- and 15N-labeled peptide containing 13C5,15N-labeled valine (Val) and 13C6,15N-labeled leucine (Leu).
  • Target Antigen:

    Isotope-Labeled Compounds
  • Type:

    Isotope-Labeled Compounds
  • Related Pathways:

    Others
  • Field of Research:

    Others
  • Assay Protocol:

    https://www.medchemexpress.com/sp-val-13c5-15n-eknq-leu-13c6-15n-tidfinivkdpvphneykt-tfa.html
  • Smiles:

    O=C([C@@H](N)CO)N1[C@H](C([15NH][13C@H]([13C](N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C([15NH][13C@H]([13C](N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N2[C@H](C(N[C@H](C(N3[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(O)=O)[C@@H](C)O)=O)CCCCN)=O)CC4=CC=C(O)C=C4)=O)CCC(O)=O)=O)CC(N)=O)=O)CC5=CNC=N5)=O)CCC3)=O)C(C)C)=O)CCC2)=O)CC(O)=O)=O)CCCCN)=O)C(C)C)=O)[C@H](CC)C)=O)CC(N)=O)=O)[C@H](CC)C)=O)CC6=CC=CC=C6)=O)CC(O)=O)=O)[C@H](CC)C)=O)[C@@H](C)O)=O)[13CH2][13CH]([13CH3])[13CH3])=O)CCC(N)=O)=O)CC(N)=O)=O)CCCCN)=O)CCC(O)=O)=O)[13CH]([13CH3])[13CH3])=O)CCC1
  • Molecular Weight:

    3152.42 (free acid)
  • References & Citations:

    [1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.
  • Shipping Conditions:

    Room temperature
  • Clinical Information:

    No Development Reported